Stock image Glp 1
3D Rendering Of Glucagon-like Peptide 1 (GLP1, 7-36) Molecule, A Potent Antihyperglycemic Hormone. A Neuropeptide And An Incretin, Treatment Of Diabetes, Molecular Surface. 3d Illustration
Image, 2.9MB, 8000 × 4500 jpg
Glucagon-like Peptide-1. Weight Loss. Physiological Functions Of GLP-1: Promote Satiety And Insulin Release, Inhibit Glucagon Secretion, Appetite, Gastric Motility And Emptying. Target Organs For Peptide Hormone. Treatment Of Diabetes. Vector Diagram
Vector, 2.25MB, 4444 × 4443 eps
GLP-1. Glucagon-like Peptide-1 For Appetite Regulation, Weight Loss And Treatment Of Diabetes. Peptide Hormone Functions And Effects On Human Internal Organs. Vector Diagram
Vector, 10.53MB, 4444 × 4444 eps
Glucagon-like Peptide-1. GLP-1 From Blood Vessel To Pancreas, Brain And Stomach. Relationship Between Satiety, Appetite Hormones, Insulin, Glucagon, Gastric Motility And Emptying. Vector Isometric Flat Illustration.
Vector, 2.58MB, 11801 × 8257 eps
One Month Supply Of Mounjaro, An Injectable Medicine Used To Treat Type 2 Diabetes.
Image, 2.77MB, 7894 × 5270 jpg
Mounjaro (Tirzepatide) Injection Pen Used By Diabetics To Aid In Glucose Management.
Image, 2.93MB, 5988 × 3992 jpg
Functions Of Glucagon-like Peptide-1. Weight Loss. GLP-1. Treatment Of Diabetes. Physiological Properties Of Peptide Hormone. Humans Internal Organs. Vector Diagram
Vector, 9.15MB, 4444 × 4444 eps
Glucagon-like Peptide Target Organs That Have The GLP-1R Receptors And Organ Related Glp Actions
Vector, 4.68MB, 5027 × 4000 eps
GLP-1 Release By The Cells Of The Small Intestine And Colon. L-cells Produce Glucagon-like Peptide In Response To Glucose, Fructose, Galactose Vector Illustration
Vector, 10.65MB, 4858 × 4000 eps
Glucagon-like Peptide 1 GLP-1 Prevents Macrovascular Complications,coronary Artery Disease, , Lipid Metabolism, Blood Pressure Inflammation, Nitric Oxide ROS, Oxygenmolecule, 2d 3d Graphic Rendering
Image, 2.47MB, 5928 × 4860 jpg
Raleigh, NC - USA - 06-13-2024: Ozempic Wegovy And Rybelsus Related Newspaper Headlines. Three Popular Semaglutide-based Prescription Diabetes And Weight Loss Drugs
Image, 3.49MB, 3232 × 2056 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.28MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.4MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.09MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: VICTOZA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.42MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.26MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: VICTOZA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.65MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: TRULICITY Box Of Medication With DULAGLUTIDE Active Substance By ELI LILLY, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.7MB, 4032 × 3024 jpg
Istanbul Turkey 27 April 2024; Glucagon Syringe Used For Hypoglycemia In Type 1 Diabetics. Syringe With Glucagon. Diabetic Coma, Hypoglycemia.
Image, 19.24MB, 7548 × 5034 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.37MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 1.95MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.32MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.32MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: VICTOZA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.41MB, 3024 × 4032 jpg
One Month Supply Of Mounjaro, An Injectable Medicine Used To Treat Type 2 Diabetes.
Image, 2.23MB, 7952 × 5304 jpg
Raleigh, NC - USA - 06-28-2024: Novo Nordisk Website Displayed On A Mobile Phone Screen With The Company Logo
Image, 2.16MB, 4290 × 2722 jpg
Prague, Czech Republic - July 10 2024: TRULICITY Box Of Medication With DULAGLUTIDE Active Substance By ELI LILLY, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.59MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.33MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.16MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: SAXENDA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Weight Loss And Diabetes Management.
Image, 2.35MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: TRULICITY Box Of Medication With DULAGLUTIDE Active Substance By ELI LILLY, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.71MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: VICTOZA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.49MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: VICTOZA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.55MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: VICTOZA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.54MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.22MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.15MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.24MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: SAXENDA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Weight Loss And Diabetes Management.
Image, 2.05MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.08MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.34MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: SAXENDA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Weight Loss And Diabetes Management.
Image, 2.2MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: SAXENDA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Weight Loss And Diabetes Management.
Image, 1.95MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: TRULICITY Box Of Medication With DULAGLUTIDE Active Substance By ELI LILLY, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.25MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: VICTOZA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.43MB, 3024 × 4032 jpg
Istanbul Turkey 27 April 2024; Glucagon Syringe Used For Hypoglycemia In Type 1 Diabetics. Syringe With Glucagon. Diabetic Coma, Hypoglycemia.
Image, 12.64MB, 7965 × 5312 jpg
Prague, Czech Republic - July 10 2024: TRULICITY Box Of Medication With DULAGLUTIDE Active Substance By ELI LILLY, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.29MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: VICTOZA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.44MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.38MB, 4032 × 3024 jpg
Page 1 >> Next